Genzyme Has More Fabrazyme Production Problems
3 CommentsBy Ed Silverman // March 23rd, 2011 // 5:18 pm
| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| « Feb | Apr » | |||||
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 | ||
• Pharma Blog » 2011 » March
Pharmalot March 23rd, 2011 Archive
Indictment Against Former Glaxo Lawyer Is Tossed
4 CommentsBy Ed Silverman // March 23rd, 2011 // 4:51 pm
Mon Dieu! AstraZeneca Pulls Bloodthinner In France
4 CommentsBy Ed Silverman // March 23rd, 2011 // 11:10 am
FDA Wants To Target ‘High Risk’ Manufacturers
5 CommentsBy Ed Silverman // March 23rd, 2011 // 10:35 am
Behind The Pfizer Curtain: Steere Exits The Board
5 CommentsBy Ed Silverman // March 23rd, 2011 // 9:44 am
KV Pharma & The Orphan Drug Act: Jamie Explains
21 CommentsBy Ed Silverman // March 23rd, 2011 // 7:37 am
Hide Side Effect Reports And Investors Can Sue
3 CommentsBy Ed Silverman // March 23rd, 2011 // 7:07 am
J&J Faces $360M Penalty Over Risperdal Marketing
4 CommentsBy Ed Silverman // March 23rd, 2011 // 7:05 am